Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity

Lupus

Volumn 16, Issue 4, 2007, Pages 265-272

  Wu, C H ^a   Hsieh, S C ^a   Li, K J ^b   Lu, M C ^b   Yu, Chia Li ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Mononuclear cells; Polymorphonuclear neutrophils; Premature telomere shortening; Systemic lupus erythematosus; Telomere length

Indexed keywords

GENOMIC DNA; TELOMERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; HUMAN; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SOUTHERN BLOTTING; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TELOMERE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TELOMERASE; TELOMERE;

EID: 34249011458     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077155     Document Type: Article

References (40)

1. Zakian VA. Telomeres: beginning to understand the end. Science 1995; 270: 1601-1607.
2. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
3. Kipling D. Telomeres, replicative senescence and human ageing. Maturitas 2001; 38: 25-38.
4. Klapper W, Parwaresch R, Krupp G. Telomere biology in human aging and aging syndromes. Mech Ageing Dev 2001; 122: 695-712.
5. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
6. Tarazona R, Solana R, Ouyang Q, Pawelec G. Basic biology and clinical impact of immunosenescence. Exp Gerontol 2002; 37: 183-189.
7. Rus V, Via CS. Telomeres, telomerase, and lupus: the long and short of it. Clin Immunol 2001; 99: 195-197.
8. Honda M, Mengesha E, Albano S et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8 + CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001; 99: 211-221.
9. Katayama Y, Kohriyama K. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol 2001; 28: 288-291.
10. Kurosaka D, Ozawa Y, Yasuda J et al. Telomerase activity in peripheral blood mononuclear cells from patients with SLE. Ann Rheum Dis 2001; 60: 1158-1159.
11. Kurosaka D, Yasuda J, Yoshida K et al. Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus 2003; 12: 591-599.
12. Klapper W, Moosig F, Sotnikova A, Qian W, Schroder JO, Parwaresch R. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1681-1683.
13. Kurosaka D, Yasuda J, Yoshida K et al. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1102-1107.
14. Schonland SO, Lopez C, Widmann T et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003; 100: 13471-13476.
15. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000; 97: 9203-9208.
16. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 5: 14447-14452.
17. Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol 1996; 35: 732-737.
18. Wu K, Higashi N, Hansen ER, Lund M, Bang K, Thestrup-Pedersen K. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 2000; 165: 4742-1747.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
20. Grossman JM, Kalunian KC. Definition, classfication, activity, and damage indices. In Wallace DJ, Hahn BH eds. Dubois' lupus erythematosus, 6th edition. Lippincott Willians & Wilkins, 2002: 19-31.
21. Hodes RJ. Telomere length, aging, and somatic cell turnover. J Exp Med 1999; 190: 153-156.
22. Allsopp RC, Vaziri H, Patterson C et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
23. Weng NP. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol 2001; 70: 861-867.
24. Widmann TA, Willmann B, Pfreundschuh M, Beelen DW. Influence of telomere length on short-term recovery after allogeneic stem cell transplantation. Exp Hematol 2005; 33: 1257-1261.
25. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58: 309-314.
26. Courtney PA, Crockard AD, Williamson K, McConnell J, Kennedy RJ, Bell AL. Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity. Lupus 1999; 8: 508-513.
27. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 2000; 908: 99-110.
28. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.
29. Serra V, von Zglinicki T, Lorenz M, Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 2003; 278: 6824-6830.
30. Alves JD, Grima B. Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis. Curr Rheumatol Rep 2003; 5: 383-390.
31. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52: 659-666.
32. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994; 55: 876-882.
33. Tsirpanlis G, Chatzipanagiotou S, Boufidou F et al. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am J Nephrol 2006; 26: 91-96.
34. Ramirez R, Carracedo J, Soriano S, Jimenez R, Martin-Malo A, Rodriguez M et al. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am J Kidney Dis 2005; 45: 353-359.
35. Boxall MC, Goodship TH, Brown AL, Ward MC, von Zglinicki T. Telomere shortening and haemodialysis. Blood Purif 2006; 24: 185-189.
36. Wallace DJ, Salonen EM, Avaniss-Aghajani E, Morris R, Metzger AL, Pashinian N. Anti-telomere antibodies in systemic lupus erythematosus: a new ELISA test for anti-DNA with potential pathogenetic implications. Lupus 2000; 9: 328-332.
37. Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Ann Rheum Dis 2004; 63: 1250-1254.
38. Bryan TM, Reddel RR. Telomere dynamics and telomerase activity in in vitro immortalized human cells. Eur J Cancer 1997; 33: 767-773.
39. Biessmann H, Mason JM. Telomere maintenance without telomerase. Chromosoma 1997; 106: 63-69.
40. Greider CW. Telomere length regulation. Annu Rev Biochem 1996; 65: 337-365.